Information Library

Results for: Brochures - Clinical Services - Phase I/IIa - Phase II/III

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Accelerating Success in Oncology

    March 9, 2012
    New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity

  • A Focus on CNS

    July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • Population PK/PD - Modeling and Simulation Optimization Tools

    February 11, 2011
    Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling.

  • The New Health Clinical Brochure

    August 31, 2010
    Japanese version available for download.

  • Targeting Oncology

    June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Emerging Biopharma Service Fact Sheet

    May 4, 2010
    Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

  • BIOS Standardize Data with SPARC

    February 2, 2010
    There is an increasing global requirement for Clinical Data Interchange Standards Consortium (CDISC) -based standardized data for regulatory submissions. At Quintiles, we have proactively addressed this need by training our staff, gaining experience, and developing and implementing innovative solutions for creating data that adhere to current CDISC Study Data Tabulation Model (SDTM) specifications.

  • Validated Biomarker Menu

    July 14, 2009
    A comprehensive menu of validated cell, fluid and tissue based biomarker assays.

  • Badania Kliniczne

    April 10, 2009
    Quintiles Poland świadczy usługi związane z organizacją i monitorowaniem Badań Klinicznych faz I-IV. Każdy nowy lek - zanim będzie dostępny w sprzedaży- musi przejść fazę wszechstronnych, specjalistycznych testów i uzyskać aprobatę organów rejestracyjnych.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences